Keane's Corner VL

ASCO 2015 - Optimal Timing of Docetaxel for Metastatic Prostate Cancer

Details
ASCO 2015 - Optimal Timing of Docetaxel for Metastatic Prostate Cancer Thomas E. Keane, MBBCh, FRCSI, FACS Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA BIOGRAPHY Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or coinve...

GU Cancers Symposium 2015 - Prostate Cancer

Details
GU Cancers Symposium 2015 - Prostate Cancer Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT : AR splice variant 7 (AR-V7) and response to taxanes in men with mCRPC - Session highlights from GU Cancers Symposium 2015 ASCENDE-RT: A multicenter, randomized trial of dose-escalated external beam radiati...

Biopsy and Re-biopsy of the Prostate: Interview with E. David Crawford, MD

Details
Best Decision Markers for Biopsy and Re-biopsy of the Prostate: Interview with E. David Crawford, MD Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT Video Lecture by E. David Crawford, MD: What are Currently the Best Decision Markers for Biopsy and Re-biopsy of the Prostate? BIOGRAPHY Thomas E. Kea...

GU Cancers Symposium 2015 - Renal & Prostate Cancers

Details
GU Cancers Symposium 2015 - Renal & Prostate Cancers Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT : Insights into E3805: The CHAARTED trial - Abstract BIOGRAPHY Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has ser...

GU Cancers Symposium 2015 - Prostate Cancer

Details
GU Cancers Symposium 2015 - Prostate Cancer Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT : Insights into E3805: The CHAARTED trial - Abstract GU Cancers Symposium 2015 - AR splice variant 7 (AR-V7) and response to taxanes in men with mCRPC GU Cancers Symposium 2015 - Bench to bedside: Androgen r...

Comparison of MR/Ultrasound Fusion-guided Biopsy with Ultrasound-guided Biopsy for PCa

Details
Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT : Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer - Abstract BIOGRA...

Review of Recent Prostate Cancer Trial Results - January 2015

Details
Review of Recent Prostate Cancer Trial Results - January 2015 Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA SEE RELATED CONTENT : Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation Therapy Oncology Group randomized clinical trial 9910 - Abstract BIOGRAPHY Thomas E. Keane, M...

Review of Highlights from 2014

Details
Review of Highlights from 2014 Xofigo® Xtandi® Zytiga® CHAARTED study PD-L1 inhibitor in metastatic bladder cancer Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA BIOGRAPHY Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as prin...

The Role of GDF-15 Expression and Vitamin D in the Prostate

Details
Reduced Expression of GDF-15 is Associated with Atrophic Inflammatory Lesions of the Prostate Thomas E. Keane, MD Professor and Chairman of the Department of Urology Medical University of South Carolina, Charleston, SC USA BIOGRAPHY Thomas E. Keane, MBBCh, FRCSI, FACS specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or...

Practical Guide to Radium-223 in mCRPC

Details
Practical Guide to Radium-223 in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) This video blog by Dr. Keane discusses a recently published review article on the background of Radium-223. Radium-223 has demonstrated survival benefits in symptomatic men with prostate cancer, while managing the pain associated with bone metastases. Thomas E. Keane, MD Professor and Chairman...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe